Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
VMF
0
API
0
FDF
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Finished Drug Prices
NA
1. 220810-26-4
2. Vantas
3. Histrelin (acetate)
4. Schembl18715
5. Chembl1200509
6. Dtxsid30176580
7. Mfcd00918679
8. 767h828
9. (des-gly10,d-his(bzl)6,pro-nhet9)-lhrh Acetate
Molecular Weight | 1383.6 g/mol |
---|---|
Molecular Formula | C68H90N18O14 |
Hydrogen Bond Donor Count | 16 |
Hydrogen Bond Acceptor Count | 17 |
Rotatable Bond Count | 34 |
Exact Mass | 1382.68838962 g/mol |
Monoisotopic Mass | 1382.68838962 g/mol |
Topological Polar Surface Area | 487 Ų |
Heavy Atom Count | 100 |
Formal Charge | 0 |
Complexity | 2690 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 9 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
1 of 2 | |
---|---|
Drug Name | Vantas |
PubMed Health | histrelin |
Drug Classes | Endocrine-Metabolic Agent |
Active Ingredient | Histrelin acetate |
Dosage Form | Implant |
Route | Subcutaneous |
Strength | 50mg |
Market Status | Prescription |
Company | Endo Pharm |
2 of 2 | |
---|---|
Drug Name | Vantas |
PubMed Health | histrelin |
Drug Classes | Endocrine-Metabolic Agent |
Active Ingredient | Histrelin acetate |
Dosage Form | Implant |
Route | Subcutaneous |
Strength | 50mg |
Market Status | Prescription |
Company | Endo Pharm |
Bachem Group is a public, innovation-driven company specializing in the development and manufacturing of peptides and oligonucleotides.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 16997
Submission : 2003-10-30
Status : Active
Type : II
RLD : No
TE Code :
Brand Name : SUPPRELIN
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : EQ 0.2MG BASE/ML
Approval Date : 1991-12-24
Application Number : 19836
RX/OTC/DISCN : DISCN
RLD : No
TE Code :
RLD : No
TE Code :
Brand Name : SUPPRELIN
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : EQ 0.5MG BASE/ML
Approval Date : 1991-12-24
Application Number : 19836
RX/OTC/DISCN : DISCN
RLD : No
TE Code :
RLD : No
TE Code :
Brand Name : SUPPRELIN
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : EQ 1MG BASE/ML
Approval Date : 1991-12-24
Application Number : 19836
RX/OTC/DISCN : DISCN
RLD : No
TE Code :
Brand Name : VANTAS
Dosage Form : IMPLANT;SUBCUTANEOUS
Dosage Strength : 50MG
Approval Date : 2004-10-12
Application Number : 21732
RX/OTC/DISCN : DISCN
RLD : Yes
TE Code :
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Brand Name : SUPPRELIN LA
Dosage Form : IMPLANT;SUBCUTANEOUS
Dosage Strength : 50MG
Approval Date : 2007-05-03
Application Number : 22058
RX/OTC/DISCN : RX
RLD : Yes
TE Code :
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Related Excipient Companies
Excipients by Applications
Global Sales Information
Patents & EXCLUSIVITIES
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?